💊
Abraxane
paclitaxel
Neoplazii ale sânului;Neoplazii pancreatice;Carcinom pulmonar cu celule non-mici
✅ Autorizat
✅
Nu există alerte active
Acest medicament nu are penurii în curs, scrisori de siguranță sau retrageri de pe piață.
La ce se utilizează
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Siguranță a pacientului
No
📚 Alerte anterioare (2)
Pagina oficială EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane